Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Clinical trial NCT06691984 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06691984
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2029-01-02
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.